Abstract
Purpose
This study was designed to evaluate the effectiveness of conservative treatment for chylous leak after tumor surgery and to propose a management algorithm.
Methods
The data of patients with postoperative chylous leak after tumor surgery in our institution between 2010 and 2019 were retrospectively reviewed. In this study, 469 laparotomies, 89 thoracotomies, and 57 cervical excisions were performed for tumor surgery in our institution.
Results
Twelve patients with a median age of 4 (IQR, 3–8) years had postoperative chylous leak. All patients received total parenteral nutrition for a median of 13 days. Five patients had intravenous somatostatin for a median of 14 days (IQR, 9–16) to decrease chyle production. Eventually, chylous leak ceased in all patients with conservative treatment and surgical drains were removed after no leak was observed with enteral feeding.
Conclusions
The incidence of chylous leak in childhood tumor surgery is approximately 2%. Extended tumor resection and lymph node dissection lead to the injury of the delicate structures that drain chyle. Conservative treatment with total parenteral nutrition and somatostatin seems to be effective. In particular, somatostatin may be used in resistant cases. Conservative treatment can take up to 1 month. The algorithm consists of how to manage postoperative chylous leak in childhood.
Similar content being viewed by others
References
Weiser AC, Lindgren BW, Ritchey ML, Franco I. Chylous ascites following surgical treatment for Wilms tumor. J Urol. 2003;170:1667–9.
Liu Y, Pan C, Tang JY, Chen J, Zhou M, Ye QD. What is the result: chylous leakage following extensive radical surgery of neuroblastoma. World J Pediatr. 2012;8:151–5.
Qureshi SS, Rent EG, Bhagat M, Dsouza P, Kembhavi S, Vora T, et al. Chyle leak following surgery for abdominal neuroblastoma. J Pediatr Surg. 2016;51:1557–60.
Pai VB, Benator R, Torres B. Refractory chylous ascites secondary to neuroblastoma. Fetal Pediatr Pathol. 2017;36:319–24.
Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc. 1980;55:700–4.
Thaler MA, Bietenbeck A, Schulz C, Luppa PB. Establishment of triglyceride cut-off values to detect chylous ascites and pleural effusions. Clin Biochem. 2017;50:134–8.
Lopez-Gutierrez JC, Tovar JA. Chylothorax and chylous ascites: management and pitfalls. Semin Pediatr Surg. 2014;23:298–302.
Evans JG, Spiess PE, Kamat AM, Wood CG, Hernandez M, Pettaway CA, et al. Chylous ascites after post-chemotherapy retroperitoneal lymph node dissection: review of the M. D. Anderson experience. J Urol. 2006;176:1463–7.
Weniger M, D’Haese JG, Angele MK, Kleespies A, Werner J, Hartwig W. Treatment options for chylous ascites after major abdominal surgery: a systematic review. Am J Surg. 2016;211:206–13.
Campisi CC, Boccardo F, Piazza C, Campisi C. Evolution of chylous fistula management after neck dissection. Curr Opin Otolaryngol Head Neck Surg. 2013;21:150–6.
Leibovitch I. Postoperative chylous ascites—the urologist’s view. Drugs Today (Barc). 2002;38:687–97.
Leibovitch I, Mor Y, Golomb J, Ramon J. The diagnosis and management of postoperative chylous ascites. J Urol. 2002;167:449–57.
Lv S, Wang Q, Zhao W, Han L, Wang Q, Batchu N, et al. A review of the postoperative lymphatic leakage. Oncotarget. 2017;8:69062–75.
Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg. 2016;49:18–24.
Loukas M, Wartmann CT, Louis RG Jr, Tubbs RS, Salter EG, Gupta AA, et al. Cisterna chyli: a detailed anatomic investigation. Clin Anat. 2007;20:683–8.
Skandalakis JE, Skandalakis LJ, Skandalakis PN. Anatomy of the lymphatics. Surg Oncol Clin N Am. 2007;16:1–16.
Johnson OW, Chick JF, Chauhan NR, Fairchild AM, Fan C-M, Stecker MS, et al. The thoracic duct: clinical importance, anatomic variation, imaging, and embolization. Eur Radiol. 2016;26:2482–93.
Aalami OO, Allen DB, Organ CH Jr. Chylous ascites: a collective review. Surgery. 2000;128:761–78.
Bhardwaj R, Vaziri H, Gautam A, Ballesteros E, Karimeddini D, Wu GY. Chylous ascites: a review of pathogenesis, diagnosis and treatment. J Clin Transl Hepatol. 2018;6:105–13.
Steven BR, Carey S. Nutritional management in patients with chyle leakage: a systematic review. Eur J Clin Nutr. 2015;69:776–80.
Jensen GL, Mascioli EA, Meyer LP, Lopes SM, Bell SJ, Babayan VK, et al. Dietary modification of chyle composition in chylothorax. Gastroenterology. 1989;97:761–5.
Molena E, King E, Davies-Husband C. Octreotide versus oral dietary modification for the treatment of chylous fistula following neck dissection: a systematic review and meta-analysis. Clin Otolaryngol. 2021;46:474–84.
Yang C, Zhang J, Wang S, Li CC, Kong XR, Zhao Z. Successful management of chylous ascites with total parenteral nutrition and octreotide in children. Nutr Hosp. 2013;28:2124–7.
Chan MM, Chan MM, Mengshol JA, Fish DN, Chan ED. Octreotide: a drug often used in the critical care setting but not well understood. Chest. 2013;144:1937–45.
Bellini C, Cabano R, De Angelis LC, Bellini T, Calevo MG, Gandulli, et al. Octreotide for congenital and acquired chylothorax in newborns: a systematic review. J Paediatr Child Health. 2018;54:840–7.
Andreou A, Papouli M, Papavasiliou V, Badouraki M. Postoperative chylous ascites in a neonate treated successfully with octreotide: bile sludge and cholestasis. Am J Perinatol. 2005;22:401–4.
Jain A, Singh SN, Singhal P, Sharma MP, Grover M. A prospective study on the role of octreotide in management of chyle fistula neck. Laryngoscope. 2015;125:1624–7.
Caverly L, Rausch CM, da Cruz E, Kaufman J. Octreotide treatment of chylothorax in pediatric patients following cardiothoracic surgery. Congenit Heart Dis. 2010;5:573–8.
Zeidan S, Delarue A, Rome A, Roquelaure B. Fibrin glue application in the management of refractory chylous ascites in children. J Pediatr Gastroenterol Nutr. 2008;46:478–81.
Carr BD, Grant CN, Overman RE, Gadepalli SK, Geiger JD. Retroperitoneal exploration with Vicryl mesh and fibrin tissue sealant for refractory chylous ascites. J Pediatr Surg. 2019;54:604–7.
Matsufuji H, Nishio T, Hosoya R. Successful treatment for intractable chylous ascites in a child using a peritoneovenous shunt. Pediatr Surg Int. 2006;22:471–3.
Huang Y, Gloviczki P, Duncan AA, Fleming MD, Driscoll DJ, Kalra M, et al. Management of refractory chylous ascites with peritoneovenous shunts. J Vasc Surg Venous Lymphat Disord. 2017;5:538–46.
Gemmete JJ, Srinivasa RN, Chick JFB. Treatment of chylous ascites in a child after wilms tumor resection with intranodal injection of N-butyl cyanoacrylate glue. J Vasc Interv Radiol. 2017;28:1067–9.
Kim J, Won JH. Percutaneous treatment of chylous ascites. Tech Vasc Interv Radiol. 2016;19:291–8.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest in association with the present study.
Ethical approval
This study was approved by our institutional ethics committee.
Informed consent
Formal consent is not required for this type of study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Ardicli, B., User, I.R., Ciftci, A.O. et al. An unusual complication of tumor surgery: chylous leakage. Surg Today 52, 330–336 (2022). https://doi.org/10.1007/s00595-021-02334-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-021-02334-1